NO865217D0 - Fremgangsmaate for fremstilling av anti-uremiapreparater. - Google Patents

Fremgangsmaate for fremstilling av anti-uremiapreparater.

Info

Publication number
NO865217D0
NO865217D0 NO865217A NO865217A NO865217D0 NO 865217 D0 NO865217 D0 NO 865217D0 NO 865217 A NO865217 A NO 865217A NO 865217 A NO865217 A NO 865217A NO 865217 D0 NO865217 D0 NO 865217D0
Authority
NO
Norway
Prior art keywords
uremia
acids
preparations
procedure
manufacture
Prior art date
Application number
NO865217A
Other languages
English (en)
Other versions
NO865217L (no
Inventor
Mackenzie Walser
Henri Bermudez
Claude Bordat
Original Assignee
Univ Johns Hopkins
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Synthelabo filed Critical Univ Johns Hopkins
Publication of NO865217D0 publication Critical patent/NO865217D0/no
Publication of NO865217L publication Critical patent/NO865217L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO865217A 1985-12-23 1986-12-22 Fremgangsmaate for fremstilling av anti-uremiapreparater. NO865217L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/812,164 US4752619A (en) 1985-12-23 1985-12-23 Nutritional supplement for treatment of uremia

Publications (2)

Publication Number Publication Date
NO865217D0 true NO865217D0 (no) 1986-12-22
NO865217L NO865217L (no) 1987-06-24

Family

ID=25208721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865217A NO865217L (no) 1985-12-23 1986-12-22 Fremgangsmaate for fremstilling av anti-uremiapreparater.

Country Status (14)

Country Link
US (1) US4752619A (no)
EP (1) EP0227545B1 (no)
JP (1) JPS62270522A (no)
KR (1) KR940002661B1 (no)
AT (1) ATE67088T1 (no)
AU (1) AU592395B2 (no)
CA (1) CA1286990C (no)
DE (1) DE3681420D1 (no)
DK (2) DK168274B1 (no)
ES (1) ES2025560T3 (no)
FI (1) FI88581C (no)
GR (1) GR3003272T3 (no)
NO (1) NO865217L (no)
PT (1) PT83995B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
SE8803143L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Alternativa energisubstrat
GB8906158D0 (en) * 1989-03-17 1989-05-04 Powell & Scholefield Limited Dietary product
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
CA2317038C (en) * 1998-01-05 2006-10-17 Mackenzie Walser Supplement for dialysis patients
WO2002081020A2 (en) * 2001-04-04 2002-10-17 Critical Therapeutics, Inc. Method for preventing acute renal failure
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
WO2007007668A1 (ja) 2005-07-08 2007-01-18 Toray Industries, Inc. 尿毒症改善のための治療剤および処置方法
RU2013151085A (ru) 2011-04-18 2015-05-27 Нестек С.А. ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ α-ГИДРОКСИИЗОКАПРОНОВУЮ КИСЛОТУ(α-HICA), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
WO2019108809A2 (en) 2017-11-29 2019-06-06 Hull Edgar L Jr Alpha keto acid compositions for treating hypo-albuminemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
DE2759133A1 (de) * 1976-12-31 1978-07-13 Carmelo Prof Giordano Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof

Also Published As

Publication number Publication date
GR3003272T3 (en) 1993-02-17
FI865268A0 (fi) 1986-12-22
CA1286990C (en) 1991-07-30
AU6691786A (en) 1987-06-25
EP0227545A2 (en) 1987-07-01
DK168274B1 (da) 1994-03-07
PT83995B (pt) 1989-09-14
DE3681420D1 (de) 1991-10-17
JPS62270522A (ja) 1987-11-24
AU592395B2 (en) 1990-01-11
PT83995A (en) 1987-01-01
DK622486A (da) 1987-06-24
EP0227545A3 (en) 1988-01-20
ATE67088T1 (de) 1991-09-15
FI88581C (fi) 1993-06-10
DK622486D0 (da) 1986-12-22
FI88581B (fi) 1993-02-26
KR870005639A (ko) 1987-07-06
NO865217L (no) 1987-06-24
US4752619A (en) 1988-06-21
ES2025560T3 (es) 1992-04-01
EP0227545B1 (en) 1991-09-11
KR940002661B1 (ko) 1994-03-28
FI865268A (fi) 1987-06-24

Similar Documents

Publication Publication Date Title
NO865217D0 (no) Fremgangsmaate for fremstilling av anti-uremiapreparater.
ES2099022A1 (es) Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
ES453476A1 (es) Procedimiento para proporcionar una fuente de proteinas en forma concentrada.
AU586892B2 (en) Pharmaceutical and dietary composition
ES2058687T3 (es) Composicion nutritiva y su procedimiento de preparacion.
ES2167338T3 (es) Composicion para tratar pacientes con enfermedades hepaticas.
IL78103A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
NO990940L (no) Ernµringssammensetning for fenylketonuripasienter
AU558812B2 (en) Dentifrice containing partially hydrolyzed protein fraction rich in positively charged amino acids
EP0744396A4 (en) COMPLEX SALTS OF PHOSPHORIC AND AMINO ACIDS AND FOOD ADDITIVES CONTAINING THEM FOR RUMBERS
AU1971988A (en) Pharmaceutical compositions for the treatment of uraemia
AU5458786A (en) Liquid dietary calcium supplementation
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
MA20303A1 (fr) Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels.
BR9814766A (pt) Formulação de revitalização
FR2053703A5 (en) Supplementary food for pregnant women
FI853504L (fi) Acetyldikarnitin.
Summers Amino acid digestibility and utilization of protein sources by poultry
PH21347A (en) N-(vinblastinoyl-23) derivatives of amino acids and pharmaceutical composition
CA777750A (en) Nutritional utilization of amino acid amides and acid salts thereof
ES8609351A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico.
IT1139477B (it) Composizione a base di lisozima in associazione con lisati proteici ed oligoelementi utile per la preparazione,eventualmente in unione ad alimenti somplici di integratori per l'alimentazione animale